Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Non Operating Investment Income (2022 - 2025)

Historic Non Operating Investment Income for Cytek Biosciences (CTKB) over the last 4 years, with Q3 2025 value amounting to $118000.0.

  • Cytek Biosciences' Non Operating Investment Income fell 3948.72% to $118000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$27000.0, marking a year-over-year decrease of 11914.89%. This contributed to the annual value of $97000.0 for FY2024, which is 43448.28% up from last year.
  • Cytek Biosciences' Non Operating Investment Income amounted to $118000.0 in Q3 2025, which was down 3948.72% from -$33000.0 recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Non Operating Investment Income ranged from a high of $195000.0 in Q3 2024 and a low of -$192000.0 during Q2 2023
  • For the 4-year period, Cytek Biosciences' Non Operating Investment Income averaged around $8833.3, with its median value being -$9500.0 (2023).
  • Within the past 5 years, the most significant YoY rise in Cytek Biosciences' Non Operating Investment Income was 120000.0% (2024), while the steepest drop was 146666.67% (2024).
  • Quarter analysis of 4 years shows Cytek Biosciences' Non Operating Investment Income stood at $17000.0 in 2022, then crashed by 117.65% to -$3000.0 in 2023, then tumbled by 1466.67% to -$47000.0 in 2024, then surged by 351.06% to $118000.0 in 2025.
  • Its last three reported values are $118000.0 in Q3 2025, -$33000.0 for Q2 2025, and -$65000.0 during Q1 2025.